We believe in what can be proved. We start with a set of jury instructions and we work our way backwards. We are skilled at making the complex more simple. This is our job as advocates and story tellers. It does not matter if you are a Fortune 100 company or an individual going up against a large corporation, your story is what matters. Essure Attorney Los Angeles help people tell compelling stories.
Cowper Law have worked with Field Medal winners, Nobel Prize laureates, and the most beloved physicians in small towns all over the country. These experts trust us. They trust us because we believe in what can be proved, we believe in the science, we understand data, we believe in evidence-based medicine, and we seek to understand the science as well as they do. That’s why they trust us in a deposition and that is why they trust us at trial.
Cowper Law is investigating whether there is a relationship between the implantation of the Essure and abnormal bleeding Los Angeles including severe pain, migration of the device, or perforation of the fallopian tube.
In a safety trial that enrolled 269 women ages 23 to 45, the device was successfully inserted into 200 patients. In nine of them, a coil perforated the fallopian tube and was expelled or lodged elsewhere in the body, according to a 2003 report in the journal Human Reproduction. Trial participants were asked to keep diaries, and nearly one in 10 participants recorded painful intercourse, while one in eight had painful menstrual periods and abnormal bleeding during the first three months.
As part of the draft guidance, the FDA also ordered Bayer to conduct a mandatory clinical study for Essure to determine heightened risks for particular women. The FDA also intends to require changes to product labeling, including a boxed warning and a Patient Decision Checklist to help to ensure women receive and understand information regarding the benefits and risks of this type of device.
Cowper Law is investigating whether there is a relationship between the implantation of the essure injury in Los Angeles including severe pain, bleeding, migration of the device, or perforation of the fallopian tube.
The Essure system is a type of permanent birth control for women. It cannot be reversed. During insertion of the Essure system, a health care provider uses a flexible tube with a small camera (hysteroscope) inserted through the vagina, into the cervix and up to the uterus. Once the openings to the fallopian tubes are visualized, small metal and fiber coils are passed through the hysteroscope and into the fallopian tubes. The Essure system causes scar tissue to form around the coils, blocking the fallopian tubes and preventing sperm from reaching the egg.
In a safety trial that enrolled 269 women ages 23 to 45, the device was successfully inserted into 200 patients. In nine of them, a coil perforated the fallopian tube and was expelled or lodged else where in the body, according to a 2003 report in the journal Human Reproduction. Trial participants were asked to keep diaries, and nearly one in 10 participants recorded painful intercourse, while one in eight had painful menstrual periods during the first three months.
In a subsequent trial of 518 women, only 449 were able to rely on the device. On 21 occasions, the implant perforated the fallopian tubes, was expelled, or ended up in the wrong place in the body. At least eight women had surgery to be sterilized or to remove a misplaced coil.
Cowper Law have worked with Field Medal winners, Nobel Prize laureates, and the most beloved physicians in small towns all over the country. These experts trust us. They trust us because we believe in what can be proved, we believe in the science, we understand data, we believe in evidence-based medicine, and we seek to understand the science as well as they do. That’s why they trust us in a deposition and that is why they trust us at trial.
Essure and abnormal bleeding Litigation In Los Angeles, Orange County
Cowper Law is investigating whether there is a relationship between the implantation of the Essure and abnormal bleeding Los Angeles including severe pain, migration of the device, or perforation of the fallopian tube.
In a safety trial that enrolled 269 women ages 23 to 45, the device was successfully inserted into 200 patients. In nine of them, a coil perforated the fallopian tube and was expelled or lodged elsewhere in the body, according to a 2003 report in the journal Human Reproduction. Trial participants were asked to keep diaries, and nearly one in 10 participants recorded painful intercourse, while one in eight had painful menstrual periods and abnormal bleeding during the first three months.
As part of the draft guidance, the FDA also ordered Bayer to conduct a mandatory clinical study for Essure to determine heightened risks for particular women. The FDA also intends to require changes to product labeling, including a boxed warning and a Patient Decision Checklist to help to ensure women receive and understand information regarding the benefits and risks of this type of device.
Essure
Cowper Law is investigating whether there is a relationship between the implantation of the essure injury in Los Angeles including severe pain, bleeding, migration of the device, or perforation of the fallopian tube.
The Essure system is a type of permanent birth control for women. It cannot be reversed. During insertion of the Essure system, a health care provider uses a flexible tube with a small camera (hysteroscope) inserted through the vagina, into the cervix and up to the uterus. Once the openings to the fallopian tubes are visualized, small metal and fiber coils are passed through the hysteroscope and into the fallopian tubes. The Essure system causes scar tissue to form around the coils, blocking the fallopian tubes and preventing sperm from reaching the egg.
In a safety trial that enrolled 269 women ages 23 to 45, the device was successfully inserted into 200 patients. In nine of them, a coil perforated the fallopian tube and was expelled or lodged else where in the body, according to a 2003 report in the journal Human Reproduction. Trial participants were asked to keep diaries, and nearly one in 10 participants recorded painful intercourse, while one in eight had painful menstrual periods during the first three months.
In a subsequent trial of 518 women, only 449 were able to rely on the device. On 21 occasions, the implant perforated the fallopian tubes, was expelled, or ended up in the wrong place in the body. At least eight women had surgery to be sterilized or to remove a misplaced coil.
